Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar 5;14(5):552.
doi: 10.3390/diagnostics14050552.

Visualization Methods for Uterine Sentinel Lymph Nodes in Early-Stage Endometrial Carcinoma: A Comparative Analysis

Linas Andreika  1 , Karolina Vankevičienė  2 , Diana Ramašauskaitė  1 , Vilius Rudaitis  1
Affiliations

Visualization Methods for Uterine Sentinel Lymph Nodes in Early-Stage Endometrial Carcinoma: A Comparative Analysis

Linas Andreika et al. Diagnostics (Basel). .

Abstract

Background: Sentinel lymph node (SLN) biopsy in early-stage endometrial cancer is recommended over systematic lymphadenectomy due to reduced morbidity and comparable detection rates. The main objective of this study was to compare the overall and bilateral detection rates of SLN in early-stage endometrial cancer using three techniques.

Methods: a prospective cohort study was designed to detect the difference in SLN detection rate in three cohorts: Indocyanine green (ICG), methylene blue (MB), and tracer combination (ICG + MB). Mapping characteristics, detection rate, number of SLNs, and positive SLNs of the three cohorts were compared.

Results: A total of 99 patients were enrolled. A total of 109 SLN sites with 164 lymph nodes were detected. No differences were found between the three cohorts in terms of age, BMI, tumor diameter, or other histologic characteristics. The overall SLN detection rate (DR) was 54.3% in the MB group, 72.7% in ICG, and 80.6% in the ICG-MB group. Bilateral DR was 22.9%, 39.4%, and 54.8% in groups, respectively, with the MB method yielding significantly inferior results.

Conclusions: The ICG-MB group demonstrated superior overall and bilateral detection rates, but a significant difference was found only in the MB cohort. Combining tracer agents can enhance the accuracy of SLN identification in initial-stage endometrial cancer without additional risk to the patient.

Keywords: endometrial cancer; endometrial carcinoma; sentinel lymph node biopsy; sentinel lymph node mapping.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
(a) Image of uterine SLN traced with MB; (b) Image of uterine SLN traced with ICG (in ICG-MB combination). Both images were observed during laparoscopic surgery.
Figure 2
Figure 2
Sites for detecting SLNs (round shape) and metastases (triangular shape).
See this image and copyright information in PMC

References

    1. Global Cancer Observatory. [(accessed on 1 February 2024)]. Available online: https://gco.iarc.fr/today/data/factsheets/cancers/24-Corpus-uteri-fact-s....
    1. Rabban J.T., Gilks C.B., Malpica A., Matias-Guiu X., Mittal K., Mutter G.L., Oliva E., Parkash V., Ronnett B.M., Staats P., et al. Issues in the Differential Diagnosis of Uterine Low-grade Endometrioid Carcinoma, Including Mixed Endometrial Carcinomas: Recommendations from the International Society of Gynecological Pathologists. Int. J. Gynecol. Pathol. 2019;38:S25–S39. doi: 10.1097/PGP.0000000000000512. - DOI - PMC - PubMed
    1. Boeckstaens S., Dewalheyns S., Heremans R., Vikram R., Timmerman D., Van den Bosch T., Verbakel J.Y. Signs and symptoms associated with uterine cancer in pre- and postmenopausal women. Heliyon. 2020;6:e05372. doi: 10.1016/j.heliyon.2020.e05372. - DOI - PMC - PubMed
    1. Talhouk A., McAlpine J.N. New classification of endometrial cancers: The development and potential applications of genomic-based classification in research and clinical care. Gynecol. Oncol. Res. Pract. 2016;3:14. doi: 10.1186/s40661-016-0035-4. - DOI - PMC - PubMed
    1. Concin N., Matias-Guiu X., Vergote I., Cibula D., Raza Mirza M., Marnitz S., Ledermann J., Bosse T., Chargari C., Fagotti A., et al. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. Int. J. Gynecol. Pathol. 2021;31:12. doi: 10.1136/ijgc-2020-002230. - DOI - PubMed

LinkOut - more resources